Circulating highly fluorescent reticulocytes to predict the adequate harvesting of peripheral blood progenitor cells in platinum-based chemotherapy

Transfusion and Apheresis Science

Volumn 27, Issue 3, 2002, Pages 199-202

  Kurata, H ^a   Takakuwa, K ^a   Tsuneki, I ^a   Aoki, Y ^a   Tanaka, K ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

CD34+ cells; CFU GM; HFR; PBPC; Platinum based chemotherapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; PEPLEOMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BIOASSAY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; LEUKAPHERESIS; PREDICTION; RETICULOCYTE; RETICULOCYTE COUNT; STEM CELL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZOPHENONEIDUM; COMBINED MODALITY THERAPY; FEMALE; FLOW CYTOMETRY; FLUORESCENT DYES; FLUOROMETRY; GENITAL NEOPLASMS, FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; RECEPTORS, COMPLEMENT 3B; RETICULOCYTE COUNT;

EID: 0036890006     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-0502(02)00065-4     Document Type: Article

References (13)

1. Aulesa C., Ortola J., Sentis M., Ortega J.J. Evaluation of the Sysmex R-3000TM automated reticulocyte analyzer. Sysmex J. Int. 3:1993;105-115.
2. Kanold J., Bezou M.J., Coulet M., Quainon F., Malpuech G., Travade Ph. et al. Evaluation of erythropoietic/hematopoietic reconstitution after BMT by fluorescent reticulocyte counts compares favorably with traditional peripheral blood cell counting. Bone Marrow Transpl. 11:1993;313-318.
3. Makino S., Harada M., Akashi K., Taniguchi S., Shibuya T., Inaba S.et al. A simplified method for cryopreservation of peripheral blood stem cells at -80 °C without rate-controlled freezing. Bone Marrow Transpl. 8:1991;239-244.
4. Eliott C., Samson D.M., Armitage S., Littelton M.P., McGuigan D., Hargreaves R.et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive concentration in peripheral blood. J. Clin. Oncol. 14:1996;970-973.
5. Armitage S., Hargreaves R., Samson D., Brennan M., Kanfer E., Navarrete C. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transpl. 20:1997;587-591.
6. Gratama J.W., Orfao A., Barnett D., Brando B., Huber A., Janossy G.et al. Flow cytometric enumeration of CD34. + hematopoietic stem and progenitor cells Cytometry. 34:1998;128-142.
7. Johnsen H.E., Baech J., Nikolajsen K. Validation of nordic flow cytometry standard for CD34. + cell enumeration in blood and autograft: report from third workshop J. Hematother. 8:1999;15-28.
8. Dzik W., Sniecinski I., Fisher J. Toward standardization of CD34. + cell enumeration: an international study Immunohematology. 39:1999;856-863.
9. Greinix H.T., Linkesch W., Keli F., Kalhs P., Schwarzinger I., Schneider B.et al. Early detection of hematopoietic engraftment after bone marrow and peripheral blood stem cell transplantation by highly fluorescent reticulocyte counts. Bone Marrow Transpl. 14:1994;307-313.
10. Sica S., Salutari P., Laurenti L., Barbera E.O.L., Zini G., d'Onofrio G.et al. Highly fluorescent reticulocytes after CD34. + peripheral blood progenitor cell transplantation Bone Marrow Transpl. 21:1998;361-364.
11. Remacha A.F., Martino R., Sureda A., Sarda M.P., Sola C., Tugues D.et al. Changes in reticulocyte fractions during peripheral stem cell harvesting: role in monitoring stem cell collection. Bone Marrow Transpl. 17:1996;163-168.
12. Mougi H., Shinmyozu K., Osame M. Determining the optimal time for peripheral blood stem cell harvest by detecting immature cells (immature leukocytes and immature reticulocytes) using two newly developed automatic cell analyzers. Int. J. Hematol. 66:1997;303-313.
13. Gowans I.D., Hepburn M.D., Clark D.M., Patterson G., Rawlinson P.S.M., Bowen D.T. The role of sysmex SE9000 immature myeloid index and sysmex R2000 reticulocyte parameters in optimizing the timing of peripheral blood stem cell harvesting in patients with lymphoma and myeloma. Clin. Lab. Haem. 21:1999;331-336.